Comparison

CASP9 Polyclonal Antibody

Item no. E-AB-10054-200
Manufacturer Elabscience
Amount 200 uL
Quantity options 120 uL 20 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications IHC
Specific against Human (Homo sapiens)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias APAF-3, APAF3, Apoptosis related cysteine peptidase, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, CASP-9, CASP9, CASP9, Caspase 9 apoptosis related cysteine peptidase, Caspase 9 Dominant Negative, Caspase 9c, Caspase-9, Caspase-9 subunit p10, ICE LAP6, ICE like apoptotic protease 6, ICE-LAP6, ICE-like apoptotic protease 6, MCH6, PPP1R56, protein phosphatase 1, regulatory subunit 56, RNCASP9
Similar products Caspase-9, CASP9, MCH6, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, ICE-like apoptotic protease 6, Caspase-9 subunit p10, protein phosphatase 1, APAF-3, APAF3, ICE-LAP6, Apoptosis related cysteine peptidase, PPP1R56, CASP-9, Caspase 9c, ICE LAP6, ICE like apoptotic protease 6, RNCASP9, Caspase 9 Dominant Negative, Caspase 9 apoptosis related cysteine peptidase, regulatory subunit 56
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
CASP9
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Manufacturer - Research Areas
Cancer, Cell Biology, Metabolism
Background
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein is processed by caspase APAF1; this step is thought to be one of the earliest in the caspase activation cascade. Alternative splicing results in two transcript variants which encode different isoforms.
Concentration
0.5 mg/mL
Buffer
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Purification Method
Affinity purification
Recommended Dilution
IHC 1:50-1:200
Santa Cruz #
sc-22182, sc-8297, sc-8355, sc-7885
Abbreviation
CASP9
Clonality
Polyclonal
Immunogen
Recombinant protein of human CASP9
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?